Stryker Corp.'s director Howard Cox Jr. will not stand for re-election at the annual shareholders meeting May 2, 2018.
Cox, who has been with the company since 1974, will be named director emeritus.
Stryker director forgoes re-election
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Stryker Corp.'s director Howard Cox Jr. will not stand for re-election at the annual shareholders meeting May 2, 2018.
Cox, who has been with the company since 1974, will be named director emeritus.